GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures

March 12, 2018, 9:00 am

≫ Next: Intensive Preoperative Ostomy Education for the Radical Cystectomy Patient

≪ Previous: Dry Needling in Stroke in Sub-Acute Phase to Improve Upper Limb

$

0

0

Condition:   Parkinson's Disease
Interventions:   Dietary Supplement: niacin;   Other: placebo
Sponsor:   VA Office of Research and Development
Recruiting

---

Intensive Preoperative Ostomy Education for the Radical Cystectomy Patient

March 12, 2018, 9:00 am

≫ Next: Comparison of a Group-delivered vs. Individually Delivered 'LiFE' Program

≪ Previous: GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures

$

0

0

Condition:   Stoma Ileostomy
Interventions:   Behavioral: Stoma Boot Camp;   Other: Standard of Care
Sponsor:   University of Kansas Medical Center
Recruiting

Comparison of a Group-delivered vs. Individually Delivered 'LiFE' Program

March 12, 2018, 9:00 am

≫ Next: Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm

≪ Previous: Intensive Preoperative Ostomy Education for the Radical Cystectomy Patient

$

0

0

Conditions:   Fall Prevention;   Exercise
Interventions:   Behavioral: iLiFE;   Behavioral: gLiFE
Sponsors:   Heidelberg University;   Robert Bosch Gesellschaft für Medizinische Forschung mbH;   University of Ulm;   Universitätsklinikum Hamburg-Eppendorf;   German Federal Ministry of Education and Research
Not yet recruiting

Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm

March 12, 2018, 9:00 am

≫ Next: PVI Alone Versus Additional Low-voltage Substrate Modification During SR Guiding by Contact-force Catheter in Older Patients With Paroxysmal AF

≪ Previous: Comparison of a Group-delivered vs. Individually Delivered 'LiFE' Program

$

0

0

Condition:   Parkinson Disease
Interventions:   Drug: Flumazenil;   Drug: Placebo
Sponsors:   University of Michigan;   National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting

PVI Alone Versus Additional Low-voltage Substrate Modification During SR Guiding by Contact-force Catheter in Older Patients With Paroxysmal AF

March 12, 2018, 9:00 am

≫ Next: Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

≪ Previous: Modulation of GABA-A Receptors in Parkinson Disease-Flumazenil Arm

$

0

0

Condition:   Paroxysmal Atrial Fibrillation
Intervention:   Procedure: PVI
Sponsors:   The First Affiliated Hospital with Nanjing Medical University;   The Affiliated Hospital of Xuzhou Medical University;   First Affiliated Hospital of Wannan Medical College;   The Second Affiliated Hospital with Nantong University;   Zhongda Hospital;   The Third Affiliated Hospital of Soochow University;   The Second Hospital of Hebei Medical University;   The First Affiliated Hospital of Soochow University;   Xuzhou Central Hospital, the Affiliated Xuzhou Hospital of Medical College of Southeast University;   Fourth Military Medical University
Not yet recruiting

Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

March 12, 2018, 9:00 am

≫ Next: Nasogastric Tube in Pancreatic Surgery

≪ Previous: PVI Alone Versus Additional Low-voltage Substrate Modification During SR Guiding by Contact-force Catheter in Older Patients With Paroxysmal AF

$

0

0

Conditions:   Plasmodium Falciparum Malaria;   Pregnancy Malaria;   Diagnoses Disease
Intervention:   Diagnostic Test: HS-RDT
Sponsors:   Foundation for Innovative New Diagnostics, Switzerland;   Burnet Institute;   Papua New Guinea Institute of Medical Research
Not yet recruiting

Nasogastric Tube in Pancreatic Surgery

March 12, 2018, 9:00 am

≫ Next: Single Ascending Oral Doses of SY-008 in Healthy Subjects

≪ Previous: Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea

$

0

0

Conditions:   Nasogastric Tube Decompression;   Pancreatic Surgery
Interventions:   Procedure: NGT group;   Procedure: non-NGT group
Sponsor:   Tongji Hospital
Not yet recruiting

Single Ascending Oral Doses of SY-008 in Healthy Subjects

March 12, 2018, 9:00 am

≫ Next: [Trial of device that is not approved or cleared by the U.S. FDA]

≪ Previous: Nasogastric Tube in Pancreatic Surgery

$

0

0

Condition:   Diabetes
Intervention:   Drug: SY-008
Sponsor:   Suzhou Yabao Pharmaceutical R&D Co., Ltd.
Recruiting

---

[Trial of device that is not approved or cleared by the U.S. FDA]

March 12, 2018, 9:00 am

≫ Next: Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™

≪ Previous: Single Ascending Oral Doses of SY-008 in Healthy Subjects

$

0

0

Condition:  
Intervention:  
Sponsor:   [Redacted]
Withheld

Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™

March 12, 2018, 9:00 am

≫ Next: A Study Comparing the Laryngeal Mask Airway Supreme With the Laryngeal Mask Airway Protector In the Ambulatory Surgery Unit

≪ Previous: [Trial of device that is not approved or cleared by the U.S. FDA]

$

0

0

Condition:   Subjects Scheduled to Undergo Laparoscopic Radical Resection of Rectal Carcinoma With Preventive Ileostomy
Interventions:   Device: INTERCEED™;   Device: Placebo
Sponsor:   Ethicon, Inc.
Not yet recruiting

A Study Comparing the Laryngeal Mask Airway Supreme With the Laryngeal Mask Airway Protector In the Ambulatory Surgery Unit

March 12, 2018, 9:00 am

≫ Next: Effect of Aerobic Exercise Associated With Abdominal Laser Therapy

≪ Previous: Prospective, Multicenter, Randomized Controlled Study to Evaluate the Effect of INTERCEED™

$

0

0

Condition:   Airway Complication of Anesthesia
Intervention:   Device: Laryngeal mask
Sponsor:   University Hospital, Ghent
Recruiting

Effect of Aerobic Exercise Associated With Abdominal Laser Therapy

March 12, 2018, 9:00 am

≫ Next: Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology

≪ Previous: A Study Comparing the Laryngeal Mask Airway Supreme With the Laryngeal Mask Airway Protector In the Ambulatory Surgery Unit

$

0

0

Condition:   Metabolic Disease
Interventions:   Device: Low level laser therapy;   Device: Aerobic Exercise;   Device: Low level laser therapy without power
Sponsor:   Escola Superior de Tecnologia da Saúde do Porto
Terminated

Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology

March 12, 2018, 9:00 am

≫ Next: Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial

≪ Previous: Effect of Aerobic Exercise Associated With Abdominal Laser Therapy

$

0

0

Conditions:   Esophageal Cancer;   Radiation Pneumonitis;   Pulmonary Fibrosis;   Respiratory Failure;   Pneumonia;   Surgery;   Chemotherapy Effect;   Radiation Fibrosis;   Radiation Toxicity;   Adenocarcinoma;   Squamous Cell Carcinoma
Intervention:   Procedure: Esophagectomy
Sponsor:   St. James's Hospital, Ireland
Completed

Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial

March 12, 2018, 9:00 am

≫ Next: ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS

≪ Previous: Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary Physiology

$

0

0

Condition:   Sickle Cell Disease
Intervention:   Behavioral: HABIT Intervention
Sponsors:   Columbia University;   National Institute of Nursing Research (NINR)
Not yet recruiting

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS

March 12, 2018, 9:00 am

≫ Next: Pilot Study of the Effects of Playing Golf on People With Dementia

≪ Previous: Hydroxyurea Adherence for Personal Best in Sickle Cell Disease (HABIT): Efficacy Trial

$

0

0

Conditions:   Acute Coronary Syndrome;   Acute Myocardial Infarction;   Coronary Artery Disease;   Percutaneous Coronary Intervention;   Platelet Aggregation Inhibitors
Interventions:   Drug: 1-months DAPT;   Drug: 12-month DAPT
Sponsor:   Kyoto University, Graduate School of Medicine
Not yet recruiting

---

Pilot Study of the Effects of Playing Golf on People With Dementia

March 12, 2018, 9:00 am

≫ Next: Effect of Lower Leg Heating and Transcutaneous Electrical Nerve Stimulation on Exercise Capacity in Patients With PAD

≪ Previous: ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study for the Patients With ACS

$

0

0

Condition:   Dementia
Intervention:   Other: Golf
Sponsor:   University of Bedfordshire
Not yet recruiting

Effect of Lower Leg Heating and Transcutaneous Electrical Nerve Stimulation on Exercise Capacity in Patients With PAD

March 12, 2018, 9:00 am

≫ Next: Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

≪ Previous: Pilot Study of the Effects of Playing Golf on People With Dementia

$

0

0

Condition:   Peripheral Arterial Disease
Interventions:   Behavioral: Lower leg heating;   Behavioral: Lower leg transcutaneous electrical nerve stimulation (TENS)
Sponsor:   Salisbury University
Recruiting

Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

March 12, 2018, 9:00 am

≫ Next: Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

≪ Previous: Effect of Lower Leg Heating and Transcutaneous Electrical Nerve Stimulation on Exercise Capacity in Patients With PAD

$

0

0

Conditions:   Recurrent Clostridium Difficile Infection;   Clostridium Difficile Infection
Interventions:   Drug: Vancomycin;   Drug: Placebo
Sponsors:   University of Wisconsin, Madison;   Indiana University;   Medical College of Wisconsin;   Agency for Healthcare Research and Quality (AHRQ)
Not yet recruiting

Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

March 12, 2018, 9:00 am

≫ Next: Treatment of Ruptured Intracranial Aneurysms in China.

≪ Previous: Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection

$

0

0

Condition:   Atrial Fibrillation
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Vitamin K antagonists (VKAs)
Sponsors:   Bayer;   Janssen Research & Development, LLC
Completed

Treatment of Ruptured Intracranial Aneurysms in China.

March 12, 2018, 9:00 am

≫ Next: Physiotherapy Program for Managing Adhesive Capsulitis in Patients With Diabetes

≪ Previous: Analysis of the Potential Savings of Rivaroxaban Events Versus Vitamin K Antagonists Events

$

0

0

Conditions:   Ruptured Intracranial Aneurysms;   Unruptured Intracranial Aneurysms;   Stent-Assisted Coiling;   Non-Stent-Assisted Coiling;   Craniotomy Clipping
Intervention:  
Sponsors:   Zhujiang Hospital;   Xuanwu hospital center image interpretation laboratory;   National center for cardiovascular disease, department of medical statistics
Not yet recruiting